Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

ADMA Biologics Inc (ADMA) vs Ocular Therapeutix, Inc. (OCUL)

ADMA Biologics Inc and Ocular Therapeutix, Inc. are both Biotechnology companies. ADMA Biologics Inc and Ocular Therapeutix, Inc. are of similar size ($2.2B and $2.1B). Ocular Therapeutix, Inc. has negative trailing earnings, so its P/E is not meaningful; ADMA Biologics Inc trades at 13.0×. ADMA Biologics Inc grew revenue faster over the last twelve months: 8.04% against −8.14%. ADMA Biologics Inc has the higher net margin (33.0% vs −579.1%) and the higher return on invested capital (29.8% vs 0.00%). Across the 18 metrics below, ADMA Biologics Inc leads on 13 and Ocular Therapeutix, Inc. on 5.

Valuation

Metric ADMA OCUL Biotechnology median
P/E 13.03 n/m 7.88
P/S 4.18 41.70 11.47
P/B 5.24 4.17 2.52
Price to free cash flow 18.42 n/m 21.16
EV/EBITDA 9.47 n/m 0.74
EV/Sales 4.30 31.60 10.73
Earnings yield 7.68% (14.72%) (28.84%)
Free cash flow yield 5.43% (11.75%) (23.03%)

Profitability

Metric ADMA OCUL Biotechnology median
Gross margin 64.71% 87.11% 65.16%
Operating margin 43.82% (603.04%) 0.00%
Net margin 32.98% (579.10%) 0.00%
Free cash flow margin 22.69% (490.07%) 0.00%
Return on equity 41.90% (72.99%) (57.72%)
Return on assets 27.19% (53.70%) (49.22%)
Return on invested capital 29.78% 0.00% 0.00%

Growth

Metric ADMA OCUL Biotechnology median
Revenue growth (TTM) 8.04% (8.14%) 5.64%
EPS growth (last fiscal year) (25.93%) (16.39%) —
Revenue growth, 5-year CAGR 64.60% 24.45% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADMA OCUL Biotechnology median
Debt to equity 0.49 0.14 0.00
Current ratio 6.97 13.11 4.73
Net debt to EBITDA (0.06) 2.51 0.96

Dividend

Metric ADMA OCUL Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ADMA OCUL Biotechnology median
Market cap 2.13b 2.16b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack